In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

which was approved for weight loss for those with obesity, or who are overweight and have a weight-related health condition, in November 2023. Although the new FDA green light doesn’t expand the ...

Never miss a story — sign up for PEOPLE's free daily newsletter to stay up-to-date on the best of what ... In March, the weight loss drug Wegovy was FDA-approved to prevent strokes and heart ...

Advertising Even before the FDA approval, some doctors have been prescribing weight-loss drugs to people with sleep apnea. The FDA’s decision may place added pressure on insurance companies to ...

The FDA also recommends that ... Shelby Knowles/Bloomberg via Getty The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep ...

21 (UPI) --Zepbound, the new GLP-1 weight-loss ... "Today's approval marks the first drug treatment option for certain patients with obstructive sleep apnea," said Dr. Sally Seymour of the FDA's ...

FDA authorizes Zyn nicotine pouches, citing public health benefits for adult smokers, despite concerns over flavored products ...

The medication also promotes weight loss, with patients losing an average ... options and eligibility for savings programs. The FDA's approval of Zepbound provides a new approach to treatment ...

The Food and Drug Administration on Friday approved Eli Lilly ... the condition by reducing body weight, according to the FDA. The move comes as weight-loss medications have garnered immense ...

The U.S. Food and Drug Administration (FDA) recently approved Zepbound® (tirzepatide ... OSA symptoms while also promoting significant weight loss. Zepbound is an injectable prescription ...